Search the Appendices of Resolution CM/Res(2018)1
1721 found
INN | ATC Code ▼ | Country | Classification | Last update | MA Number | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
FEDRATINIB | L01XE57 | RS | Not authorised | 02-06-2021 | VALID | |||
PADELIPORFIN | L01XD07 | RS | POM | 29-03-2018 | EMEA/H/C/004182 | 15-11-2017 | VALID | |
AMINOLEVULINIC ACID | L01XD04 | RS | Not authorised | 29-05-2017 | VALID | |||
CETUXIMAB | L01XC06 | RS | POM | VALID | ||||
TRASTUZUMAB | L01XC03 | RS | Not authorised | 13-05-2024 | VALID | |||
NIVOLUMAB AND RELATLIMAB | L01FY02 | RS | Not authorised | 23-11-2022 | VALID | |||
PERTUZUMAB AND TRASTUZUMAB | L01FY01 | RS | POM | VALID | ||||
ELRANATAMAB | L01FX32 | RS | Not authorised | 13-05-2024 | VALID | |||
TALQUETAMAB | L01FX29 | RS | Not authorised | 20-11-2023 | VALID | |||
GLOFITAMAB | L01FX28 | RS | Not authorised | 20-11-2023 | VALID | |||
LONCASTUXIMAB TESIRINE | L01FX22 | RS | Not authorised | VALID | ||||
TREMELIMUMAB | L01FX20 | RS | Not authorised | VALID | ||||
AMIVANTAMAB | L01FX18 | RS | Not authorised | 23-11-2022 | VALID | |||
SACITUZUMAB GOVITECAN | L01FX17 | RS | Not authorised | 23-11-2022 | VALID | |||
POLATUZUMAB VEDOTIN | L01FX14 | RS | POM | 27-01-2022 | VALID | |||
ENFORTUMAB VEDOTIN | L01FX13 | RS | Not authorised | 23-11-2022 | VALID | |||
TAFASITAMAB | L01FX12 | RS | Not authorised | 12-10-2021 | VALID | |||
OLARATUMAB | L01FX10 | RS | Not authorised | 29-05-2017 | VALID | |||
MOGAMULIZUMAB | L01FX09 | RS | Not authorised | 27-01-2022 | VALID | |||
ELOTUZUMAB | L01FX08 | RS | Not authorised | 21-11-2016 | VALID | |||
BLINATUMOMAB | L01FX07 | RS | Not authorised | VALID | ||||
DINUTUXIMAB BETA | L01FX06 | RS | Not authorised | VALID | ||||
BRENTUXIMAB VEDOTIN | L01FX05 | RS | POM | VALID | ||||
IPILIMUMAB | L01FX04 | RS | Not authorised | VALID | ||||
GEMTUZUMAB OZOGAMICIN | L01FX02 | RS | Not authorised | 12-11-2018 | VALID | |||
RAMUCIRUMAB | L01FG02 | RS | Not authorised | VALID | ||||
TISLELIZUMAB | L01FF09 | RS | Not authorised | 20-11-2023 | VALID | |||
DOSTARLIMAB | L01FF07 | RS | Not authorised | 12-10-2021 | VALID | |||
CEMIPLIMAB | L01FF06 | RS | Not authorised | VALID | ||||
ATEZOLIZUMAB | L01FF05 | RS | POM | 27-01-2022 | VALID | |||
AVELUMAB | L01FF04 | RS | Not authorised | VALID | ||||
DURVALUMAB | L01FF03 | RS | POM | 27-01-2022 | VALID | |||
PEMBROLIZUMAB | L01FF02 | RS | POM | 27-01-2022 | VALID | |||
NIVOLUMAB | L01FF01 | RS | Not authorised | 12-04-2016 | VALID | |||
NECITUMUMAB | L01FE03 | RS | Not authorised | 21-11-2016 | VALID | |||
PANITUMUMAB | L01FE02 | RS | POM | VALID | ||||
TRASTUZUMAB DERUXTECAN | L01FD04 | RS | Not authorised | 12-10-2021 | VALID | |||
TRASTUZUMAB EMTANSINE | L01FD03 | RS | POM | VALID | ||||
PERTUZUMAB | L01FD02 | RS | POM | VALID | ||||
TRASTUZUMAB | L01FD01 | RS | POM | VALID | ||||
ISATUXIMAB | L01FC02 | RS | Not authorised | 07-10-2020 | VALID | |||
DARATUMUMAB | L01FC01 | RS | POM | 27-01-2022 | VALID | |||
MOXETUMOMAB PASUDOTOX | L01FB02 | RS | Not authorised | 02-06-2021 | VALID | |||
INOTUZUMAB OZOGAMICIN | L01FB01 | RS | Not authorised | 06-11-2017 | VALID | |||
OBINUTUZUMAB | L01FA03 | RS | POM | VALID | ||||
OFATUMUMAB | L01FA02 | RS | Not authorised | VALID | ||||
RITUXIMAB | L01FA01 | RS | POM | VALID | ||||
PRALSETINIB | L01EX23 | RS | Not authorised | 23-11-2022 | VALID | |||
SELPERCATINIB | L01EX22 | RS | Not authorised | 02-06-2021 | VALID | |||
RIPRETINIB | L01EX19 | RS | Not authorised | 23-11-2022 | VALID |